专题：Autoimmune and Inflammatory Disorders

This cluster of papers focuses on the association between neutrophilic dermatoses, such as Pyoderma Gangrenosum and Sweet's Syndrome, and inflammatory bowel diseases. It covers various aspects including clinical features, treatment strategies, pathophysiology, and potential links with autoinflammatory skin disorders.
最新文献
Ileocaecal resection versus infliximab for ileal Crohn's disease: retrospective 10-year follow-up of the LIR!C trial

article Full Text OpenAlex

Dissecting Cellulitis of the Scalp Associated With Dupilumab: A Paradoxical Neutrophilic Reaction

article Full Text OpenAlex

Probable Stricturing in Small Bowel Crohn Disease: In Support of SAR Consensus Recommendations

article Full Text OpenAlex

Distinct microbial mediators link diet to inflammation in Crohn’s disease and ulcerative colitis

article Full Text OpenAlex

Efficacy and safety of low-dose interleukin 2 for Behçet’s syndrome: a randomized, placebo-controlled, double-blind, phase 2 clinical trial

article Full Text OpenAlex

Generalised granuloma annulare following ustekinumab therapy for palmoplantar psoriasis

article Full Text OpenAlex

‘Dory flop’ sign: an under-recognised indicator of primary syphilis

article Full Text OpenAlex

TL1A-activated T cells remodel the rectal mucosa in patients with Crohn’s disease with perianal fistulising disease

article Full Text OpenAlex

Rituximab-Induced Esophageal Ulcers and Strictures Presenting as Dysphagia

article Full Text OpenAlex

Individual components and cumulative burden of metabolic syndrome are associated with higher disease activity and adverse outcomes in Crohn’s disease

article Full Text OpenAlex

近5年高被引文献
Crohn's disease

review Full Text OpenAlex 392 FWCI223.1032

Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease

article Full Text OpenAlex 382 FWCI121.3455

ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment

article Full Text OpenAlex 255 FWCI144.2083

ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease

article Full Text OpenAlex 238 FWCI75.6027

Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments

review Full Text OpenAlex 204 FWCI29.6212

Inflammatory Bowel Disease

review Full Text OpenAlex 191 FWCI60.3551

Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study

article Full Text OpenAlex 189 FWCI34.0001

Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility

article Full Text OpenAlex 175 FWCI32.3115

Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)

article Full Text OpenAlex 132 FWCI39.7604

Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn’s Disease

article Full Text OpenAlex 128 FWCI72.4816